PBM logo

Psyence Biomedical (PBM) Financials

Balance sheets

Sep 1, 2024Sep 1, 2023Sep 1, 2022

Total Assets

$2.3 M(+238.5%)$665.8 K-

Current Assets

$2.2 M(+236.9%)$665.8 K-

Non Current Assets

$10.1 K(+100.0%)$0.0-

Total Liabilities

$3.5 M(+113.5%)$1.6 M-

Current Liabilities

$3.5 M(+113.5%)$1.6 M-

Long Term Liabilities

$0.0(0%)$0.0-

Shareholders Equity

-$1.3 M(-28.4%)-$977.4 K-

Book Value

-$1.3 M(-28.4%)-$977.4 K-

Working Capital

-$1.3 M(-29.4%)-$977.4 K-

Cash And Cash Equivalents

$1.9 M(+222.9%)$598.4 K-

Accounts Payable

$805.6 K(-11.5%)$910.1 K-

Accounts Receivable

---

Short Term Debt

$2.5 M(+241.1%)$733.1 K-

Long Term Debt

---

Total Debt

$2.5 M(+241.1%)$733.1 K(+100.0%)$0.0

Debt To Equity

-2.0(-165.3%)-0.8-

Current Ratio

0.6(+56.1%)0.4-

Quick Ratio

---

Inventory

---

Retained Earnings

-$54.5 M--

PB Ratio

-5.5--

Income statements

Sep 1, 2024Sep 1, 2023Sep 1, 2022

EPS

$38.3(+2199.0%)-$1.8(-26.6%)-$1.4

TTM EPS

$38.3(+2199.0%)-$1.8(-26.6%)-$1.4

Revenue

---

TTM Revenue

---

Total Expenses

$1.2 M(+556.7%)$176.2 K(-27.8%)$244.0 K

Operating Expenses

$1.2 M(+556.7%)$176.2 K(-27.8%)$244.0 K

Cost Of Goods Sold

---

TTM Cost Of Goods Sold

---

Gross Profit

---

TTM Gross Profit

---

Gross Margin

---

Operating Profit

-$1.2 M(-556.7%)-$176.2 K(+27.8%)-$244.0 K

TTM Operating Profit

-$1.2 M(-556.7%)-$176.2 K(+27.8%)-$244.0 K

Operating Margin

---

Net Income

$141.5 K(+145.7%)-$309.7 K(-26.6%)-$244.7 K

TTM Net Income

$141.5 K(+145.7%)-$309.7 K(-26.6%)-$244.7 K

Net Margin

---

EBIT

$145.2 K(+151.5%)-$281.7 K(-15.4%)-$244.0 K

TTM EBIT

$145.2 K(+151.5%)-$281.7 K(-15.4%)-$244.0 K

EBITDA

$146.2 K(+151.9%)-$281.7 K(-15.4%)-$244.0 K

TTM EBITDA

$146.2 K(+151.9%)-$281.7 K(-15.4%)-$244.0 K

Selling, General & Administrative Expenses

$890.5 K(+382.1%)$184.7 K(-23.7%)$242.1 K

TTM SGA

$890.5 K(+382.1%)$184.7 K(-23.7%)$242.1 K

Depreciation And Amortization

$1800.0(+100.0%)$0.0-

TTM D&A

$1800.0(+100.0%)$0.0-

Interest Expense

$3700.0(-86.7%)$27.9 K-

TTM Interest Expense

$3700.0(-86.7%)$27.9 K-

Income Tax

---

TTM Income Tax

---

PE Ratio

0.8--

PS Ratio

---

Cashflow statements

Sep 1, 2024Sep 1, 2023Sep 1, 2022

Cash From Operations

-$1.5 M(+4.5%)-$1.6 M(-192.8%)-$542.4 K

TTM CFO

-$1.5 M(+4.5%)-$1.6 M(-192.8%)-$542.4 K

Cash From Investing

-$6400.0(-100.0%)$0.0(0%)$0.0

TTM CFI

-$6400.0(-100.0%)$0.0(0%)$0.0

Cash From Financing

$2.7 M(+216.7%)$859.3 K(+187.8%)-$979.2 K

TTM CFF

$2.7 M(+216.7%)$859.3 K(+187.8%)-$979.2 K

Free Cash Flow

-$1.5 M(+4.1%)-$1.6 M(-192.8%)-$542.4 K

TTM FCF

-$1.5 M(+4.1%)-$1.6 M(-192.8%)-$542.4 K

CAPEX

---

TTM CAPEX

---

Dividends Paid

---

TTM Dividends Paid

---

TTM Dividend Per Share

---

TTM Dividend Yield

---

Payout Ratio

---